Predicting pediatric inflammatory bowel disease remission utilizing a clinical decision support tool
Journal of Pediatric Gastroenterology and Nutrition · 2026-06 · 82 (6) · 1435-1440
DOI: 10.1002/jpn3.70401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 18.03.2026. Verfasst von Erica Rabinovich und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Northwell Health, New Hyde Park, New York, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Inflammatory Bowel Diseases, Decision Support Systems, Clinical, Gastrointestinal Agents. Die Arbeit nennt 21 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Objectives
A clinical decision support tool (CDST) endorsed by The American Gastroenterological Association predicts likelihood of inflammatory bowel disease (IBD) remission in adults based on the advanced therapy selected. In children who are given these same therapies, predictors of response may differ from those in adults. The aim of this study is to establish the CDST's ability to predict remission in a pediatric IBD population treated with non‐anti‐tumor necrosis factor (TNF) biologics.
Methods
A single center retrospective review of IBD patients 2–21 years of age who received either vedolizumab (VDZ) or ustekinumab (UST) between 2018 and 2023 was performed. Subjects were either biologic naïve or had prior anti‐TNF exposure. Baseline clinical characteristics were used to generate a CDST score. This score was compared to week 52 outcomes after starting VDZ or UST in the full cohort, divided by IBD diagnosis, and medication choice. A dichotomized cut‐off score of > or ≤19 indicating high or low probability of steroid free clinical remission (SFR) was then used in the same analysis as well as groups separated by anti‐TNF exposure status.
Results
One hundred seventy subjects were included. SFR at Week 52 of VDZ or UST was achieved in 108/170 (64%) of patients. SFR at Week 52 was significantly associated with CDST score in the full cohort ( p < 0.001), in UC ( p = 0.0015) and in CD ( p = 0.043) subjects. SFR at Week 52 was significantly associated with dichotomized CDST cut‐off score in full cohort ( p < 0.001), UC ( p < 0.005) and CD ( p < 0.021) subjects. CDST score >19 had high sensitivity for predicting SFR at Week 52 in full cohort and when separated by disease state. In the anti‐TNF exposed cohort, SFR at Week 52 was significantly associated with dichotomized CDST cut‐off score of 19 ( p < 0.0037). No significant association was seen in anti‐TNF naive cohort. When separated by medical therapy, significant association seen with both continuous ( p < 0.001) and dichotomized ( p < 0.001) CDST score and SFR in patients treated with VDZ. No significant association was seen with patients treated with UST.
Conclusions
The CDST appears to have applicability for predicting week 52 SFR in children with UC or CD. CDST score of >19 is a highly sensitive cut point for predicting SFR in our pediatric IBD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Northwell Health, New Hyde Park, New York, USA.
- Biostatistics Unit, Office of Academic Affairs, Northwell, Manhasset, New York, USA.
- Feinstein Institutes For Medical Research, Northwell, Manhasset, New York, USA.
ORCID-Profile: Erica Rabinovich
Förderung
- None
Zitieren
APA
Rabinovich, E., Markowitz, J. F., Cerise, J., Zinkin, J., & Sahn, B. (2026). Predicting pediatric inflammatory bowel disease remission utilizing a clinical decision support tool. Journal of Pediatric Gastroenterology and Nutrition, 82(6), 1435-1440. https://doi.org/10.1002/jpn3.70401
Vancouver
Rabinovich E, Markowitz JF, Cerise J, Zinkin J, Sahn B. Predicting pediatric inflammatory bowel disease remission utilizing a clinical decision support tool. Journal of Pediatric Gastroenterology and Nutrition. 2026;82(6):1435-1440. doi:10.1002/jpn3.70401
BibTeX
@article{Rabinovich2026,
author = {Rabinovich, Erica and Markowitz, James F and Cerise, Jane and Zinkin, Julia and Sahn, Benjamin},
title = {Predicting pediatric inflammatory bowel disease remission utilizing a clinical decision support tool},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
volume = {82},
number = {6},
pages = {1435--1440},
doi = {10.1002/jpn3.70401}
}
EUVIMED